Kashiv Biosciences is a fully integrated biopharmaceutical company, the company offers advanced drug delivery technology, biosimilars, and special pharmaceutical products to strategic partners, physicians, and patients worldwide.
Employees: 51-200
Total raised: $150M
Founded date: 2019
Funding Rounds 1
| Date | Series | Amount | Investors |
| 08.04.2025 | - | $150M | - |
Mentions in press and media 2
| Date | Title | Description |
| 08.04.2025 | Kashiv BioSciences: $150 Million Debt Financing Raised From GoldenTree Asset Management | Kashiv BioSciences, a fully integrated biopharmaceutical company, announced that it has entered a senior secured credit agreement with GoldenTree Asset Management as the sole lender. The $150 million credit facility supports Kashiv BioScien... |
| - | Kashiv BioSciences | “Kashiv BioSciences is a fully-integrated biopharmaceutical company with global R&D, clinical, manufacturing, regulatory, and IP capabilities.” |